Resektabilität und Indikation zur Chemotherapie kolorektaler Lebermetastasen: Internistische Onkologen und Viszeralchirurgen bewerten unterschiedlich
K Homayounfar , A Bleckmann , HJ Helms , F Lordick
Zeitschrift Fur Gastroenterologie 50 ( 08)
2012
AgNORs correlate with clinical behaviour and response to octreotide therapy in endocrine GEP-tumours
J Rüschoff , M Frank , H Lenze , ME Trautmann
Regulatory Peptides 40 ( 2) 241
1992
Erstbeschreibung einer Mikrosatelliteninstabilität und Ausfall von hMLH1 im seltenen serös-oligozystischen Adenom des Pankreas (SOIA) bei einem Patienten mit Hereditärem Non-Polypösen Colorectalen Carcinom (HNPCC)
M Petersen , M Evert , R Schneider-Stock , M Pross
Zeitschrift Fur Gastroenterologie 46 ( 09)
2008
HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer
R Schulz , F Streller , A H Scheel , J Rüschoff
Cell Death and Disease 5 ( 1)
51
2014
Enhancement of experimental metastasis by tumor necrosis factor
P Orosz , B Echtenacher , W Falk , J Rüschoff
Journal of Experimental Medicine 177 ( 5) 1391 -1398
156
1993
Unusual Nodular Regenerative Hyperplasia Mimicking Liver Metastases in CEUS
M Höpfner , A Scheel , M Braun , J Rüschoff
Ultraschall in der Medizin - European Journal of Ultrasound 35 ( 3) 199 -202
2014
ToGA Trial Investigators: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
YJ Bang , Eric Van Cutsem , A Feyereislova , Hyun C Chung
Lancet 376 ( 9742) 687 -697
358
2010
Schilddrüse
J Feldkamp , KM Schulte , K Schmid , JT Heverhagen
Praxis der Viszeralchirurgie: Endokrine Chirurgie 29 -227
2
2013
Colorectal serrated adenoma: diagnostic criteria and clinical implications
J Rüschoff , D Aust , A Hartmann
Verhandlungen der Deutschen Gesellschaft fur Pathologie 91 119 -125
21
2007
Hereditäres Dickdarmkarzinom
TT Rau , H Dawson , A Hartmann , J Rüschoff
Der Pathologe 3 ( 38) 156 -163
4
2017
Pathology of familial tumor syndromes
A Hartmann , J Rüschoff
Der Pathologe 31 ( 6) 410 -411
1
2010
Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: the pathologists' perspective
R Salgado , V Peg , J Rüschoff , A Vincent-Salomon
Annals of Oncology 32 ( 11) 1316 -1321
4
2021
HER2 testing in gastric cancer: results of a meeting of German experts
G Baretton , M Dietel , T Gaiser , T Kirchner
Der Pathologe 37 361 -366
11
2016
Lapatinib Versus Lapatinib Plus Capecitabine As Second-Line Treatment in Her2-Overexpressing Metastatic Gastro-Esophageal Cancer (Gc): a Randomized Phase Ii Trial of the Arbeitsgemeinschaft Internistische Onkologie (Aio)
S Lorenzen , U Helbig , J Riera-Knorrenschild , GM Haag
Annals of Oncology 25 iv215 -iv215
2014
Industrieforum
M von Knebel Doeberitz , C von Knebel Doeberitz , H Friess , J Kleeff
Visceral Medicine 15 ( 2) 202 -203
1999
Band 15, Heft 2, Juni 1999
M von Knebel Doeberitz , C von Knebel Doeberitz , H Friess , J Kleeff
Visceral Medicine 15 ( 2) 105 -108
1999
Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer
PK Wagner , A Ramaswamy , J Rüschoff , P Schmitz-Moormann
Journal of British Surgery 78 ( 7) 825 -827
203
1991
Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy
M Hofmann , O Stoss , T Gaiser , H Kneitz
Journal of clinical pathology 61 ( 1) 89 -94
153
2008
Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours
P Kornprat , P Rehak , J Rüschoff , C Langner
Journal of Clinical Pathology 59 ( 2) 202 -206
38
2006
Genomic rearrangements of hMSH6 contribute to the genetic predisposition in suspected hereditary non-polyposis colorectal cancer syndrome
J Plaschke , J Rüschoff , HK Schackert
Journal of Medical Genetics 40 ( 8) 597 -600
29
2003